1520. Respiratory Syncytial Virus Hospitalizations (RSVH) and All-Cause Bronchiolitis Hospitalizations (BH) Among Children Aged ≤ 24 Months at the Start of RSV Season With Bronchopulmonary Dysplasia/Chronic Lung Disease of Prematurity (BPD/CLDP) Before and After the 2014 American Academy of Pediatrics (AAP) Policy

BACKGROUND: The AAP, in 2014, stopped endorsing palivizumab for use in children with BPD/CLDP born at < 32 weeks’ gestational age (wGA) between the ages of 12 to 24 months not requiring medical support during the 6 months before the start of RSV season and all children with BPD/CLDP born at >...

Descripción completa

Detalles Bibliográficos
Autores principales: Fergie, Jaime, Gonzales, Tara, Suh, Mina, Jiang, Xiaohui, Fryzek, Jon, Howard, Ashley, Bloomfield, Adam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Poster Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7778126/
http://dx.doi.org/10.1093/ofid/ofaa439.1701

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7778126/
http://dx.doi.org/10.1093/ofid/ofaa439.1701

Ejemplares similares